New drug checking data from the Trans-European Drug Information (TEDI) network

Data from drug checking services across Europe provide us with valuable insights into drug market dynamics and can help warn users of dangerous substances in circulation. Analysing such data is part of the EMCDDA's multi-indicator approach to drug monitoring and provides crucial information for local interventions. Today, the EMCDDA has released the latest drug-checking data from the Trans-European Drug Information (TEDI) network, with which it has been collaborating since 2017.

The data are presented in interactive maps, which allow individuals to look at geographical and temporal patterns and to zoom in on results by drug, year, semester and city. At present, the substances covered are: amphetamine, cocaine, heroin, ketamine, MDMA pills and MDMA powder.

These interactive features have been designed to be accessible and user-friendly and to perform better on mobile and desktop devices. In line with the EMCDDA’s commitment to open data, all of the source tables behind the tool can be easily downloaded by researchers, data journalists or anyone interested in using the data in their work.